199 related articles for article (PubMed ID: 19523780)
1. Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
Spiewak M; Malek LA; Misko J; Chojnowska L; Milosz B; Klopotowski M; Petryka J; Dabrowski M; Kepka C; Ruzyllo W
Eur J Radiol; 2010 Jun; 74(3):e149-53. PubMed ID: 19523780
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 3D phase-sensitive inversion-recovery and 2D inversion-recovery MRI at 3.0 T for the assessment of late gadolinium enhancement in patients with hypertrophic cardiomyopathy.
Morita K; Utsunomiya D; Oda S; Komi M; Namimoto T; Hirai T; Hashida M; Takashio S; Yamamuro M; Yamashita Y
Acad Radiol; 2013 Jun; 20(6):752-7. PubMed ID: 23473721
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
6. Visual estimation of the extent of myocardial hyperenhancement on late gadolinium-enhanced CMR in patients with hypertrophic cardiomyopathy.
Doesch C; Huck S; Böhm CK; Michaely H; Fluechter S; Haghi D; Dinter D; Borggrefe M; Papavassiliu T
Magn Reson Imaging; 2010 Jul; 28(6):812-9. PubMed ID: 20409668
[TBL] [Abstract][Full Text] [Related]
7. Registration of dynamic multiview 2D ultrasound and late gadolinium enhanced images of the heart: Application to hypertrophic cardiomyopathy characterization.
Betancur J; Simon A; Halbert E; Tavard F; Carré F; Hernández A; Donal E; Schnell F; Garreau M
Med Image Anal; 2016 Feb; 28():13-21. PubMed ID: 26619189
[TBL] [Abstract][Full Text] [Related]
8. Optimization of single injection liver arterial phase gadolinium enhanced MRI using bolus track real-time imaging.
Sharma P; Kalb B; Kitajima HD; Salman KN; Burrow B; Ray GL; Martin DR
J Magn Reson Imaging; 2011 Jan; 33(1):110-8. PubMed ID: 21182128
[TBL] [Abstract][Full Text] [Related]
9. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
[TBL] [Abstract][Full Text] [Related]
10. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
[TBL] [Abstract][Full Text] [Related]
11. [Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance].
Pujadas S; Carreras F; Arrastio X; Leta R; Vila M; Subirana MT; Bayés-Genís A; Pons-Lladó G
Rev Esp Cardiol; 2007 Jan; 60(1):10-4. PubMed ID: 17288950
[TBL] [Abstract][Full Text] [Related]
12. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.
Amano Y; Takayama M; Kumita S
J Magn Reson Imaging; 2009 Oct; 30(4):778-84. PubMed ID: 19787718
[TBL] [Abstract][Full Text] [Related]
14. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
[TBL] [Abstract][Full Text] [Related]
16. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
17. Free breathing three-dimensional late gadolinium enhancement cardiovascular magnetic resonance using outer volume suppressed projection navigators.
Menon RG; Miller GW; Jeudy J; Rajagopalan S; Shin T
Magn Reson Med; 2017 Apr; 77(4):1533-1543. PubMed ID: 27122450
[TBL] [Abstract][Full Text] [Related]
18. Measuring aortic diameter with different MR techniques: comparison of three-dimensional (3D) navigated steady-state free-precession (SSFP), 3D contrast-enhanced magnetic resonance angiography (CE-MRA), 2D T2 black blood, and 2D cine SSFP.
Potthast S; Mitsumori L; Stanescu LA; Richardson ML; Branch K; Dubinsky TJ; Maki JH
J Magn Reson Imaging; 2010 Jan; 31(1):177-84. PubMed ID: 20027585
[TBL] [Abstract][Full Text] [Related]
19. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy.
Fattori R; Biagini E; Lorenzini M; Buttazzi K; Lovato L; Rapezzi C
Am J Cardiol; 2010 Jun; 105(11):1592-6. PubMed ID: 20494668
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity.
Aquaro GD; Masci P; Formisano F; Barison A; Strata E; Pingitore A; Positano V; Spirito P; Lombardi M
Am J Cardiol; 2010 Feb; 105(3):392-7. PubMed ID: 20102955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
